From acute to long-term alterations in pain processing and modulation after spinal cord injury: mechanisms related to chronification of central neuropathic pain.


Journal

Pain
ISSN: 1872-6623
Titre abrégé: Pain
Pays: United States
ID NLM: 7508686

Informations de publication

Date de publication:
01 Jan 2022
Historique:
received: 03 12 2020
accepted: 10 04 2021
pubmed: 18 4 2021
medline: 7 1 2022
entrez: 17 4 2021
Statut: ppublish

Résumé

A severe and debilitating consequence of a spinal cord injury (SCI) is central neuropathic pain (CNP). Our aim was to investigate the processes leading to CNP emergence and chronification by analyzing causal relationship over time between spinothalamic function, pain excitability, and pain inhibition after SCI. This longitudinal follow-up study included 53 patients with acute SCI and 20 healthy controls. Spinothalamic, pain excitability, and intrasegmental and extrasegmental pain inhibition indices were repeatedly evaluated at 1.5, 3, and 6 months post-SCI. Between- and within-group analyses were conducted among those patients who eventually developed CNP and those who did not. Healthy controls were evaluated twice for repeatability analysis. Patients who developed CNP, compared with those who did not, exhibited increased thermal thresholds (P < 0.05), reduced pain adaptation (P < 0.01), and conditioned pain modulation (P < 0.05), early post-injury, and the CNP group's manifestations remained worse throughout the follow-up. By contrast, allodynia frequency was initially similar across SCI groups, but gradually increased in the subacute phase onward only among the CNP group (P < 0.001), along with CNP emergence. Early worse spinothalamic and pain inhibition preceded CNP and predicted its occurrence, and early worse pain inhibition mediated the link between spinothalamic function and CNP. Crossover associations were observed between early and late pain inhibition and excitability. Inefficient intrasegmental and extrasegmental inhibition, possibly resulting from spinothalamic deafferentation, seems to ignite CNP chronification. Pain excitability probably contributes to CNP maintenance, possibly via further exhaustion of the inhibitory control. Preemptive treatment promoting antinociception early post-SCI may mitigate or prevent CNP.

Identifiants

pubmed: 33863855
doi: 10.1097/j.pain.0000000000002315
pii: 00006396-202201000-00027
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e94-e105

Informations de copyright

Copyright © 2021 International Association for the Study of Pain.

Références

Albu S, Gómez-Soriano J, Avila-Martin G, Taylor J. Deficient conditioned pain modulation after spinal cord injury correlates with clinical spontaneous pain measures. PAIN 2015;156:260–72.
Attal N, Mazaltarine G, Perrouin-Verbe B, Albert T, SOFMER French Society for Physical Medicine and Rehabilitation. Chronic neuropathic pain management in spinal cord injury patients. What is the efficacy of pharmacological treatments with a general mode of administration? (oral, transdermal, intravenous). Ann Phys Rehabil Med 2009;52:124–41.
Baastrup C, Jensen TS, Finnerup NB. Pregabalin attenuates place escape/avoidance behavior in a rat model of spinal cord injury. Brain Res 2011;1370:129–35.
Bingel U, Herken W, Teutsch S, May A. Habituation to painful stimulation involves the antinociceptive system—a 1-year follow-up of 10 participants. PAIN 2008;140:393–94.
Bosma RL, Cheng JC, Rogachov A, Kim JA, Hemington KS, Osborne NR, Venkat Raghavan L, Bhatia A, Davis KD. Brain dynamics and temporal summation of pain predicts neuropathic pain relief from ketamine infusion. Anesthesiology 2018;129:1015–24.
Bryce TN, Biering-Sørensen F, Finnerup NB, Cardenas DD, Defrin R, Lundeberg T, Norrbrink C, Richards JS, Siddall P, Stripling T, Treede ND, Waxman SG, Widerström-Noga E, Yezierski RB, Dijkers M. International spinal cord injury pain classification: part I. Background and description. Spinal Cord 2012;50:413–7.
Burke D, Fullen BM, Stokes D, Lennon O. Neuropathic pain prevalence following spinal cord injury: a systematic review and meta-analysis. Eur J Pain 2017;21:29–44.
Coronel MF, Villar MJ, Brumovsky PR, González SL. Spinal neuropeptide expression and neuropathic behavior in the acute and chronic phases after spinal cord injury: effects of progesterone administration. Peptides 2017;88:189–95.
Cruz-Almeida Y, Felix ER, Martinez-Arizala A, Widerström-Noga EG. Decreased spinothalamic and dorsal column medial lemniscus-mediated function is associated with neuropathic pain after spinal cord injury. J Neurotrauma 2012;29:2706–15.
Dennis SG, Melzack R. Pain-signalling systems in the dorsal and ventral spinal cord. PAIN 1977;4:97–132.
Drew GD, Siddall PJ, Duggan AW. Mechanical allodynia following contusion injury of the rat spinal cord is associated with loss of GABAergic inhibition in the dorsal horn. PAIN 2004;109:379–88.
Ducreux D, Attal N, Parker F, Bouhassira D. Mechanisms of central neuropathic pain: a combined psychophysical and fMRI study in syringomyelia. Brain 2006;129:963–76.
Finnerup NB, Sørensen L, Biering-Sørensen F, Johannesen IL, Jensen TS. Segmental hypersensitivity and spinothalamic function in spinal cord injury pain. Exp Neurol 2007;207:139–49.
Finnerup NB, Norrbrink C, Trok K, Piehl F, Johannesen IL, Sørensen JC, Jensen TS, Werhagen L. Phenotypes and predictors of pain following traumatic spinal cord injury: a prospective study. J Pain 2014;15:40–8.
Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, Gilron I, Haanpää M, Hansson P, Jensen TS, Kamerman PR, Lund K, Moore A, Raja SN, Rice AS, Rowbotham M, Sena E, Siddall P, Smith BH, Wallace M. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol 2015;14:162–73.
Georgieva M, Wei Y, Dumitrascuta M, Pertwee R, Finnerup NB, Huang W. Fatty acid suppression of glial activation prevents central neuropathic pain after spinal cord injury. PAIN 2019;160:2724–42.
Gruener H, Zeilig G, Laufer Y, Blumen N, Defrin R. Differential pain modulation properties in central neuropathic pain after spinal cord injury. PAIN 2016;157:1415–24.
Gruener H, Zeilig G, Gaidukov E, Rachamim-Katz O, Ringler E, Blumen N, Engel-Haber E, Defrin R. Biomarkers for predicting central neuropathic pain occurrence and severity after spinal cord injury: results of a long-term longitudinal study. PAIN 2020;161:545–56.
Gustin SM, Wrigley PJ, Youssef AM. Thalamic activity and biochemical changes in individuals with neuropathic pain following spinal cord injury HHS Public Access. PAIN 2014;155:1027–36.
Gwak YS, Hulsebosch CE. Neuronal hyperexcitability: a substrate for central neuropathic pain after spinal cord injury. Curr Pain Headache Rep 2011;15:215–22.
Gwak YS, Hulsebosch CE, Leem JW. Neuronal-glial interactions maintain chronic neuropathic pain after spinal cord injury. Neural Plast 2017;2017:2480689.
Hains BC, Saab CY, Waxman SG. Changes in electrophysiological properties and sodium channel Nav1.3 expression in thalamic neurons after spinal cord injury. Brain 2005;128:2359–71.
Hari AR, Wydenkeller S, Dokladal P, Halder P. Enhanced recovery of human spinothalamic function is associated with central neuropathic pain after SCI. Exp Neurol 2009;216:428–30.
Hoffman JM, Bombardier CH, Graves DE, Kalpakjian CZ, Krause JS. A longitudinal study of depression from 1 to 5 years after spinal cord injury. Arch Phys Med Rehabil 2011;92:411–18.
Hosseini M, Karami Z, Yousefifard M, Janzadeh A, Zamani E, Nasirinezhad F. Simultaneous intrathecal injection of muscimol and endomorphin-1 alleviates neuropathic pain in rat model of spinal cord injury. Brain Behav 2020;10:e01576.
Jensen TS, Finnerup NB. Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms. Lancet Neurol 2014;13:924–35.
Jutzeler CR, Huber E, Callaghan MF. Association of pain and CNS structural changes after spinal cord injury. Sci Rep 2016;6:1–13.
Kramer JL, Minhas NK, Jutzeler CR, Erskine EL, Liu LJ, Ramer MS. Neuropathic pain following traumatic spinal cord injury: models, measurement, and mechanisms. J Neurosci Res 2017;95:1295–306.
Kumru H, Soler D, Vidal J, Tormos JM, Pascual-Leone A, Valls-Sole J. Evoked potentials and quantitative thermal testing in spinal cord injury patients with chronic neuropathic pain. Clin Neurophysiol 2012;123:598–604.
Lenz FA, Kwan HC, Dostrovsky JO, Tasker RR. Characteristics of the bursting pattern of action potentials that occurs in the thalamus of patients with central pain. Brain Res 1989;496:357–60.
Li X, Wang L, Chen Q, Hu Y, Du J, Chen X, Zheng W, Lu J, Chen N The reorganization of insular subregions in individuals with below-level neuropathic pain following incomplete spinal cord injury. Neural Plasticity 2020;2020:2796571.
Lockwood S, Dickenson AH. What goes up must come down: insights from studies on descending controls acting on spinal pain processing. J Neural Transm (Vienna) 2020;127:541–9.
Masri R, Quiton RL, Lucas JM, Murray PD, Thompson SM, Keller A. Zona incerta: a role in central pain. J Neurophysiol 2009;102:181–91.
Mehta S, McIntyre A, Janzen S, Loh E, Teasell R. Spinal cord injury rehabilitation evidence team. Systematic review of pharmacologic treatments of pain after spinal cord injury: an update. Arch Phys Med Rehabil 2016;97:1381–91.
Nauta HJ, McIlwrath SL, Westlund KN. Punctate midline myelotomy reduces pain responses in a rat model of lumbar spine pain: evidence that the postsynaptic dorsal column pathway conveys pain from the axial spine. Cureus 2018;10:e2371.
Park A, Uddin O, Li Y, Masri R, Keller A. Pain after spinal cord injury is associated with abnormal presynaptic inhibition in the posterior nucleus of the thalamus. J Pain 2018;19:727–e1.
Pattany PM, Yezierski RP, Widerström-Noga EG. Proton magnetic resonance spectroscopy of the thalamus in patients with chronic neuropathic pain after spinal cord injury. Am J Neuroradiol 2002;23:901–5.
Preacher KJ, Hayes AF. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods 2008;40:879–91.
Putatunda R, Hala TJ, Chin J, Lepore AC. Chronic at-level thermal hyperalgesia following rat cervical contusion spinal cord injury is accompanied by neuronal astrocyte activation and loss of the astrocyte glutamate transporter, GLT1, in superficial dorsal horn. Brain Res 2014;1581:64–79.
Scheuren PS, Gagné M, Jutzeler CR, Rosner J, Mercier C, Kramer JLK. Tracking changes in neuropathic pain after acute spinal cord injury. Front Neurol 2019;10:90.
Seminowicz DA, Jiang L, Ji Y, Xu S, Gullapalli RP, Masri R. Thalamocortical asynchrony in conditions of spinal cord injury pain in rats. J Neurosci 2012;32:15843–8.
Stanwell P, Siddall P, Keshava N, Cocuzzo D, Ramadan S, Lin A, Herbert D, Craig A, Tran Y, Middleton J, Gautam S, Cousins M, Mountford C. Neuro magnetic resonance spectroscopy using wavelet decomposition and statistical testing identifies biochemical changes in people with spinal cord injury and pain. Neuroimage 2010;53:544–52.
Vierck C. Mechanisms of below-level pain following spinal cord injury (SCI). J Pain 2020; 21: 262–80.
Vogel C, Rukwied R, Stockinger L. Functional characterization of at-level hypersensitivity in patients with spinal cord injury. J Pain 2017;18:66–78.
Wang G, Thompson SM. Maladaptive homeostatic plasticity in a rodent model of central pain syndrome: thalamic hyperexcitability after spinothalamic tract lesions. J Neurosci 2008;28:11959–69.
Warner F, Cragg JJ, Jutzeler C, Finnerup NB, Werhagen L, Weidner N, Maier D, Kalke YB, Curt A, Kramer JLK. Progression of neuropathic pain after acute spinal cord injury: a meta-analysis and framework for clinical trials. J Neurotrauma 2019;36:1461–68.
Wasner G, Lee BB, Engel S, McLachlan E. Residual spinothalamic tract pathways predict development of central pain after spinal cord injury. Brain 2008;131:2387–400.
Watanabe S, Uchida K, Nakajima H, Matsuo H, Sugita D, Yoshida A, Honjoh K, Johnson WE, Baba H. Early transplantation of mesenchymal stem cells after spinal cord injury relieves pain hypersensitivity through suppression of pain-related signaling cascades and reduced inflammatory cell recruitment. Stem Cells 2015;33:1902–14.
Widerström-Noga E, Pattany PM, Cruz-Almeida Y. Metabolite concentrations in the anterior cingulate cortex predict high neuropathic pain impact after spinal cord injury. PAIN 2013;154:204–12.
Widerström-Noga E, Cruz-Almeida Y, Felix ER, Pattany PM. Somatosensory phenotype is associated with thalamic metabolites and pain intensity after spinal cord injury. PAIN 2015;156:166–74.
Widerström-Noga E, Felix ER, Adcock JP, Escalona M, Tibbett J. Multidimensional neuropathic pain phenotypes after spinal cord injury. J Neurotrauma 2016;33:482–92.
Wollaars MM, Post MW, van Asbeck FW, Brand N. Spinal cord injury pain: the influence of psychologic factors and impact on quality of life. Clin J Pain 2007;23:383–91.
Wrigley PJ, Press SR, Gustin SM, Macefield VG, Gandevia SC, Cousins MJ, Middleton JW, Henderson LA, Siddall PJ. Neuropathic pain and primary somatosensory cortex reorganization following spinal cord injury. PAIN 2009;141:52–9.
Wu J, Raver C, Piao C, Keller A, Faden AI. Cell cycle activation contributes to increased neuronal activity in the posterior thalamic nucleus and associated chronic hyperalgesia after rat spinal cord contusion. Neurotherapeutics 2013;10:520–38.
Wydenkeller S, Maurizio S, Dietz V, Halder P. Neuropathic pain in spinal cord injury: significance of clinical and electrophysiological measures. Eur J Neurosci 2009;30:91–9.
Yarnitsky D, Arendt-Nielsen L, Bouhassira D. Recommendations on terminology and practice of psychophysical DNIC testing. Eur J Pain 2010;14:339.
Yezierski RP, Liu S, Ruenes GL, Kajander KJ, Brewer KL. Excitotoxic spinal cord injury: behavioral and morphological characteristics of a central pain model. PAIN 1998;75:141–55.
Zeilig G, Enosh S, Rubin-Asher D, Lehr B, Defrin R. The nature and course of sensory changes following spinal cord injury: predictive properties and implications on the mechanism of central pain. Brain 2012;135:418–30.

Auteurs

Ruth Defrin (R)

Department of Physical Therapy at Sackler Faculty of Medicine and Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.

Hila Gruener (H)

Department of Physical Therapy at Sackler Faculty of Medicine and Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.

Evgeni Gaidukov (E)

Department of Neurological Rehabilitation, Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
Department of Rehabilitation Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Moshe Bondi (M)

Department of Neurological Rehabilitation, Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
Department of Rehabilitation Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Orna Rachamim-Katz (O)

Barzilai Day Care Rehabilitation Unit, Barzilai Medical Center, Ashkelon, Israel.

Erez Ringler (E)

Department of Neurological Rehabilitation, Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
Department of Rehabilitation Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Nava Blumen (N)

Department of Neurological Rehabilitation, Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
Department of Rehabilitation Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Gabi Zeilig (G)

Department of Neurological Rehabilitation, Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.
Department of Rehabilitation Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH